These increases in RBC glycolytic proteins were reported to be consistent with a theoretically improved capacity of Hb to off-load oxygen modulation by high-energy phosphate compounds, perhaps to counteract COVID-19-induced hypoxia. The gene discussed is GSTM1; the disease is COVID-19.